Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

EP-NIR Analyzers

By Drug Discovery Trends Editor | October 5, 2007

SpectrometersAspectrics manufactures a complete line of Infrared and Near Infrared spectrometers for both at-line and on-line process related applications. The company’s ncoded Photometric Infrared (EP-IR) and Near Infrared (EP-NIR) analyzers offer an alternative to traditional NIR systems, with a spectral range extending further than the common 2100nm and achieving a range of 1375-2750nm.

Aspectrics’ EP-IR technology allows users to monitor their processes in real-time. The company’s patented Encoder Disk technology provides a fast sampling capability of 100 scans/second resulting in multi component analysis. Achieving this fast scan rate and with an extended warranty of ten years on the motor, Aspectrics offers 30 billion scans over the life of the instrument or 10 years of life.

Aspectrics has recently extended its one year warranty on its EP-NIR and EP-IR spectrometers to three years for parts and labor as well as adding a new ten year parts and labor warranty on the encoder disk motor. In addition, the warranties now include all parts and labor for repair at the company’s Pleasanton, Calif. facility.
www.aspectrics.com

Published in Drug Discovery & Development magazine: Vol. 10, No. 8, August, 2007, p.34.


Filed Under: Drug Discovery

 

Related Articles Read More >

China’s biopharma sector enters ‘innovation 2.0’ era
The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE